相关实验视频

Updated: Mar 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

使用可解释机器学习模型预测恶性胆道阻塞患者的术后存活率:一个多中心研究

Zongdong Zhu¹, Chenyang Bian^2,3, Linjing Zhao⁴

¹Zunyi Medical University, Zunyi, Guizhou, China.

Cancer medicine

|March 6, 2026

概括

这项研究使用机器学习开发了恶性胆道阻塞 (MBO) 存活率的预测模型. 经过验证的XGBoost AFT模型准确预测结果,有助于个性化患者治疗.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
医疗信息学医疗信息学

背景情况:

对患有恶性胆道阻塞 (MBO) 的患者来说,内镜胆道疏通至关重要.
改善MBO患者的生存率和生活质量是临床的关键目标.
准确预测术后存活率对于有效管理至关重要.

研究的目的:

确定影响MBO患者术后生存的关键因素.
开发和验证MBO患者生存率的预测模型.
为指导个性化治疗策略和术后护理.

主要方法:

来自三家医院的337名MBO患者 (2013-2021) 的回顾性数据分析.
机器学习模型的应用:梯度增强的生存树,XGBoost,XGBoost AFT,随机生存森林和Cox回归.
模型性能使用一致性指数 (C指数) 进行评估;SHapley添加式解释 (SHAP) 进行解释.

主要成果:

XGBoost加速失效时间 (AFT) 模型表现出卓越的性能 (C指数: 0.902 训练, 0.722 测试 1, 0.705 测试 2).
确定了关键的生存预测因素:远程转移,高总胆红素,延长的前热血素时间和高水平阻塞.
卡普兰-梅尔分析证实了高风险和低风险组的有效风险分层.

结论:

一个强大的,外部验证的XGBoost AFT模型准确地预测MBO患者的术后存活率.
该模型为优化术后管理提供了有价值的见解.
结果支持个性化治疗方法,以改善患者的治疗结果.

关键词:

胆道排水胆道排水内镜逆行性胆血管造机图 (cholangiopancreatography) 是一种内镜逆行式胆血管造机图.机器学习是机器学习.恶性胆道阻塞胆道阻塞

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...